Abrons, Ron O.
Ten Eyck, Patrick
Sheffield, Isaac D.
Article History
Received: 13 October 2020
Accepted: 26 February 2021
First Online: 29 March 2021
Declarations
:
: This trial, and all experimental methods and protocols within, were reviewed and approved by the University of Iowa Institutional Review Board prior to patient recruitment (reference number 201704829). All methods were carried out in accordance with relevant guidelines and regulations. The study principle investigator (R.A.) or one of three research assistants reviewed the risks and benefits of the study with each patient. Written informed consent was obtained from all participants.
: Not applicable.
: Dr. Ron Abrons, the primary investigator, is the inventor, but not the intellectual property owner, of the AOA. He stands to benefit financially if the AOA is commercially successful via agreement with the University of Iowa Research Foundation.